|
|
|
|
|
|
|
The Alzheimer's Association, the Alzheimer's Impact Movement (AIM), the Association's advocacy arm, and our nationwide network of dedicated advocates, including the generous and dedicated members of NARFE, have worked tirelessly to grow bipartisan support in Congress to make Alzheimer's research funding a priority. This month we celebrate continued success in those efforts. With the $414 million increase passed last month by Congress and signed by the president, Alzheimer's and dementia research funding at the federal government is $1.8 billion. This latest increase was secured by Senate Appropriations Labor, Health and Human Services, Education and Related Agencies Subcommittee Chairman Roy Blunt (R‐Mo.) and Ranking Member Patty Murray (D‐Wash.), and by House Appropriations Labor, Health and Human Services, Education and Related Agencies Subcommittee Chairman Tom Cole (R‐Okla.) and House Appropriations Committee Ranking Member Nita Lowey (D‐N.Y.). We are grateful to the members of NARFE for the important role their support plays in this and in all our efforts to advance Alzheimer's research and advocacy.
|
|
|
Major Alzheimer's and dementia research funding increase signed into law
The $414 million increase for Alzheimer's and dementia research funding at the National Institutes of Health (NIH) marks the third year in a row that the largest federal increase in Alzheimer's research funding has been signed into law. The bill also included Kevin and Avonte's Law, important legislation to protect those who wander. The Alzheimer's Association, the Alzheimer's Impact Movement (AIM), the Association's advocacy arm, and our nationwide network of dedicated advocates have worked tirelessly to grow support in Congress for these two priorities. This victory couldn't have happened without this combined effort and advocates like you. Learn more.
|
|
|
|
|
Alzheimer's Disease 2018 Facts and Figures released
The Alzheimer's Association 2018 Alzheimer's Disease Facts and Figures report reveals sharp increases in Alzheimer's prevalence, deaths and cost of care. New findings show the growing burden of Alzheimer's on people living with the disease, their families and caregivers, as well as society at large. An accompanying special report shows that early and accurate diagnosis could save up to $7.9 trillion in medical and care costs. The report also highlights the financial and personal benefits of early diagnosis. Watch the video.
|
|
|
|
|
Daytime drowsiness in elderly adults may increase Alzheimer's disease risk
A new study in the journal JAMA Neurology suggests that excessive daytime sleepiness in cognitively normal elderly adults may be associated with the buildup of plaques made of beta-amyloid protein — one of the hallmark brain changes of Alzheimer's disease. While further research is necessary, if this finding is confirmed, it could create a revealing question that doctors can ask when assessing people who may be living with Alzheimer's or another dementia. Learn more.
|
|
|
|
|
Join Our Mailing List
|
|
|
|
|
NARFE Contributions to Advance Alzheimer's Research
NARFE 2018 GOAL $13 MILLION
|
|
|
|
24/7 Helpline: 1-800-272-3900
|
|
